Literature DB >> 16554578

Hepatic metastases: perilesional enhancement on dynamic MRI.

Jeong-Sik Yu1, Neil M Rofsky.   

Abstract

OBJECTIVE: Our purpose was to determine whether the perilesional parenchymal enhancement of hepatic metastases could be correlated with tumoral enhancement on arterial phase images or tumor size on dynamic MRI.
MATERIALS AND METHODS: One hundred thirty-four lesions of hepatic metastases in 44 patients were subjected to a retrospective analysis of the dynamic MR images obtained with 3D spoiled gradient-echo sequences. The thickness of the enhancing rim on arterial phase images was regarded as a summation of the enhancing component of tumor periphery and perilesional enhancement, which were estimated by the tumor size on precontrast T1-weighted images. The presence of wedge-shaped perilesional enhancement was also correlated with the lesion size.
RESULTS: Except for 17 diffusely enhanced lesions, lesion size was comparable between the lesions with (n = 87; 26 +/- 19 [SD] mm) and without rim enhancement (n = 30; 27 +/- 23 mm) on the arterial phase dynamic MR images (p > 0.05). The degree of peripheral tumoral enhancement showed an inverse correlation (r = -0.389) with the thickness of the circumferential perilesional enhancement (p < 0.001). The mean size of the lesions with wedge-shaped perilesional enhancement (n = 44; 33 +/- 20 mm) was larger than that of the other lesions (n = 90; 25 +/- 19 mm) (p = 0.016).
CONCLUSION: The degree of circumferential perilesional enhancement of hepatic metastases on arterial phase dynamic MR images would be independent of the lesion size but inversely correlated with the degree of peripheral tumoral vascularity. An understanding of these features may help tumor characterization and should prompt hypotheses and studies of microvascular phenomena in tumoral and epitumoral environments.

Entities:  

Mesh:

Year:  2006        PMID: 16554578     DOI: 10.2214/AJR.04.1698

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.

Authors:  Albert Liao; Pardeep Mittal; David H Lawson; Jenny J Yang; Eszter Szalai; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2017-11-06       Impact factor: 12.079

2.  Differentiation of histopathological growth patterns of colorectal liver metastases by MRI features.

Authors:  Wen-Hui Li; Shuai Wang; Yi Liu; Xin-Fang Wang; Yong-Feng Wang; Rui-Mei Chai
Journal:  Quant Imaging Med Surg       Date:  2022-01

Review 3.  CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.

Authors:  Shenglin Li; Zhengxiao Li; Xiaoyu Huang; Peng Zhang; Juan Deng; Xianwang Liu; Caiqiang Xue; Wenjuan Zhang; Junlin Zhou
Journal:  Abdom Radiol (NY)       Date:  2022-07-27

4.  Dynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysis.

Authors:  Hanping Wu; Agata A Exner; Hong Shi; Joshua Bear; John R Haaga
Journal:  Acad Radiol       Date:  2009-12       Impact factor: 3.173

5.  Contrast-enhanced ultrasound in planning thermal ablation of liver metastases: Should the hypervascular halo be included in the ablation volume?().

Authors:  A Andreano; E Meneghel; G Bovo; D Ippolito; A Salvioni; C Filice; S Sironi; M F Meloni
Journal:  J Ultrasound       Date:  2010-11-18

Review 6.  Imaging of liver metastases: MRI.

Authors:  Saravanan Namasivayam; Diego R Martin; Sanjay Saini
Journal:  Cancer Imaging       Date:  2007       Impact factor: 3.909

7.  Radiofrequency ablation of liver metastases from colorectal cancer: a literature review.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  Gut Liver       Date:  2012-12-05       Impact factor: 4.519

8.  Native T1 mapping for assessment of the perilesional zone in metastases and benign lesions of the liver.

Authors:  Ute Lina Fahlenkamp; Katharina Ziegeler; Lisa Christine Adams; Sarah Maria Böker; Günther Engel; Marcus Richard Makowski
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.